• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Nitric oxide induces CD4+CD25+ Foxp3 regulatory T cells from CD4+CD25 T cells via p53, IL-2, and OX40.一氧化氮通过p53、白细胞介素-2和OX40从CD4+CD25 T细胞诱导产生CD4+CD25+Foxp3调节性T细胞。
Proc Natl Acad Sci U S A. 2007 Sep 25;104(39):15478-83. doi: 10.1073/pnas.0703725104. Epub 2007 Sep 17.
2
Characterization of protective human CD4CD25 FOXP3 regulatory T cells generated with IL-2, TGF-β and retinoic acid.用 IL-2、TGF-β 和维 A 酸诱导产生的保护性人 CD4CD25 FOXP3 调节性 T 细胞的鉴定。
PLoS One. 2010 Dec 17;5(12):e15150. doi: 10.1371/journal.pone.0015150.
3
Stimulation of α7 nicotinic acetylcholine receptor by nicotine increases suppressive capacity of naturally occurring CD4+CD25+ regulatory T cells in mice in vitro.尼古丁刺激 α7 烟碱型乙酰胆碱受体可增加体外培养的小鼠天然存在的 CD4+CD25+调节性 T 细胞的抑制能力。
J Pharmacol Exp Ther. 2010 Dec;335(3):553-61. doi: 10.1124/jpet.110.169961. Epub 2010 Sep 15.
4
Plasmodium falciparum-mediated induction of human CD25Foxp3 CD4 T cells is independent of direct TCR stimulation and requires IL-2, IL-10 and TGFbeta.恶性疟原虫介导的人类CD25Foxp3 CD4 T细胞诱导不依赖于直接的TCR刺激,且需要白细胞介素-2、白细胞介素-10和转化生长因子β。
PLoS Pathog. 2009 Aug;5(8):e1000543. doi: 10.1371/journal.ppat.1000543. Epub 2009 Aug 14.
5
[Depressive effect of cigarette smoke extracts on dendritic cells inducing differentiation of CD4+T cells into CD4+CD25+Foxp3+ Tregs].[香烟烟雾提取物对诱导树突状细胞将CD4 + T细胞分化为CD4 + CD25 + Foxp3 +调节性T细胞的抑制作用]
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2016 Jan;32(1):15-9.
6
Hepatic stellate cells preferentially expand allogeneic CD4+ CD25+ FoxP3+ regulatory T cells in an IL-2-dependent manner.肝星状细胞以白细胞介素-2依赖的方式优先扩增同种异体CD4+CD25+FoxP3+调节性T细胞。
Transplantation. 2008 Dec 15;86(11):1492-502. doi: 10.1097/TP.0b013e31818bfd13.
7
The maintenance of human CD4+ CD25+ regulatory T cell function: IL-2, IL-4, IL-7 and IL-15 preserve optimal suppressive potency in vitro.人CD4+ CD25+调节性T细胞功能的维持:白细胞介素-2、白细胞介素-4、白细胞介素-7和白细胞介素-15在体外保持最佳抑制效力。
Int Immunol. 2007 Jun;19(6):785-99. doi: 10.1093/intimm/dxm047. Epub 2007 Jun 1.
8
CD4+CD25-LAG3+ regulatory T cells controlled by the transcription factor Egr-2.由转录因子Egr-2控制的CD4+CD25-LAG3+调节性T细胞。
Proc Natl Acad Sci U S A. 2009 Aug 18;106(33):13974-9. doi: 10.1073/pnas.0906872106. Epub 2009 Aug 4.
9
The IL-4 receptor alpha-chain-binding cytokines, IL-4 and IL-13, induce forkhead box P3-expressing CD25+CD4+ regulatory T cells from CD25-CD4+ precursors.白细胞介素4受体α链结合细胞因子白细胞介素4和白细胞介素13可从CD25-CD4+前体细胞诱导出表达叉头框P3的CD25+CD4+调节性T细胞。
J Immunol. 2005 Nov 1;175(9):6107-16. doi: 10.4049/jimmunol.175.9.6107.
10
Cutting edge: OX40 inhibits TGF-beta- and antigen-driven conversion of naive CD4 T cells into CD25+Foxp3+ T cells.前沿:OX40抑制转化生长因子β和抗原驱动的初始CD4 T细胞向CD25+Foxp3+ T细胞的转变。
J Immunol. 2007 Aug 1;179(3):1427-30. doi: 10.4049/jimmunol.179.3.1427.

引用本文的文献

1
Regulatory T cells in solid tumor immunotherapy: effect, mechanism and clinical application.实体瘤免疫治疗中的调节性T细胞:作用、机制及临床应用
Cell Death Dis. 2025 Apr 11;16(1):277. doi: 10.1038/s41419-025-07544-w.
2
Maintenance of graft tissue-resident Foxp3+ cells is necessary for lung transplant tolerance in mice.维持移植组织驻留的Foxp3+细胞对小鼠肺移植耐受是必要的。
J Clin Invest. 2025 Mar 18;135(10). doi: 10.1172/JCI178975. eCollection 2025 May 15.
3
Tumor NOS2 and COX2 Spatial Juxtaposition with CD8+ T Cells Promote Metastatic and Cancer Stem Cell Niches that Lead to Poor Outcome in ER- Breast Cancer.肿瘤 NOS2 和 COX2 与 CD8+T 细胞的空间毗邻促进转移和癌症干细胞生态位形成,导致 ER- 乳腺癌不良预后。
Cancer Res Commun. 2024 Oct 1;4(10):2766-2782. doi: 10.1158/2767-9764.CRC-24-0235.
4
Inhibitors of NLRP3 Inflammasome Formation: A Cardioprotective Role for the Gasotransmitters Carbon Monoxide, Nitric Oxide, and Hydrogen Sulphide in Acute Myocardial Infarction.NLRP3 炎性小体形成抑制剂:气体递质一氧化碳、一氧化氮和硫化氢在急性心肌梗死中的心脏保护作用。
Int J Mol Sci. 2024 Aug 26;25(17):9247. doi: 10.3390/ijms25179247.
5
Gut redox and microbiome: charting the roadmap to T-cell regulation.肠道氧化还原状态和微生物组:绘制 T 细胞调控的路线图。
Front Immunol. 2024 Aug 21;15:1387903. doi: 10.3389/fimmu.2024.1387903. eCollection 2024.
6
Targeting amino acid-metabolizing enzymes for cancer immunotherapy.针对氨基酸代谢酶的癌症免疫疗法。
Front Immunol. 2024 Aug 14;15:1440269. doi: 10.3389/fimmu.2024.1440269. eCollection 2024.
7
Biopterin metabolism and nitric oxide recoupling in cancer.癌症中的生物蝶呤代谢与一氧化氮再偶联
Front Oncol. 2024 Feb 26;13:1321326. doi: 10.3389/fonc.2023.1321326. eCollection 2023.
8
The Macrophage Activator GcMAF-RF Enhances the Antitumor Effect of Karanahan Technology through Induction of M2-M1 Macrophage Reprogramming.巨噬细胞激活因子 GcMAF-RF 通过诱导 M2-M1 巨噬细胞重编程增强了 Karanahan 技术的抗肿瘤作用。
J Immunol Res. 2024 Feb 29;2024:7484490. doi: 10.1155/2024/7484490. eCollection 2024.
9
NOS2 and COX2 Provide Key Spatial Targets that Determine Outcome in ER- Breast Cancer.一氧化氮合酶2(NOS2)和环氧化酶2(COX2)提供了决定雌激素受体阴性(ER-)乳腺癌预后的关键空间靶点。
bioRxiv. 2023 Dec 23:2023.12.21.572859. doi: 10.1101/2023.12.21.572859.
10
Amino acid metabolism reprogramming: shedding new light on T cell anti-tumor immunity.氨基酸代谢重编程:为 T 细胞抗肿瘤免疫带来新的曙光。
J Exp Clin Cancer Res. 2023 Nov 3;42(1):291. doi: 10.1186/s13046-023-02845-4.

本文引用的文献

1
Pillars Article: An Essential Role for Scurfin in CD4+CD25+ T Regulatory Cells. Nat. Immunol. 2003. 4: 337-342.专题文章:斯卡尔芬在CD4+CD25+调节性T细胞中的重要作用。《自然免疫学》。2003年。第4卷:337 - 342页。
J Immunol. 2017 Feb 1;198(3):993-998.
2
Pillars Article: Foxp3 Programs the Development and Function of CD4+CD25+ Regulatory T Cells. Nat. Immunol. 2003. 4: 330-336.支柱文章:Foxp3调控CD4+CD25+调节性T细胞的发育与功能。《自然免疫学》,2003年,第4卷,第330 - 336页。
J Immunol. 2017 Feb 1;198(3):986-992.
3
Pillars Article: Control of Regulatory T Cell Development by the Transcription Factor Foxp3. Science 2003. 299: 1057-1061.支柱文章:转录因子Foxp3对调节性T细胞发育的控制。《科学》2003年。299卷:1057 - 1061页。
J Immunol. 2017 Feb 1;198(3):981-985.
4
Coexpression of CD25 and CD27 identifies FoxP3+ regulatory T cells in inflamed synovia.CD25和CD27的共表达可识别炎症滑膜中的FoxP3+调节性T细胞。
J Exp Med. 2005 Jun 6;201(11):1793-803. doi: 10.1084/jem.20050085.
5
Sustained survivin expression from OX40 costimulatory signals drives T cell clonal expansion.来自OX40共刺激信号的持续生存素表达驱动T细胞克隆扩增。
Immunity. 2005 May;22(5):621-31. doi: 10.1016/j.immuni.2005.03.012.
6
Induction of T helper type 1-like regulatory cells that express Foxp3 and protect against airway hyper-reactivity.诱导表达Foxp3并预防气道高反应性的1型辅助性T样调节细胞。
Nat Immunol. 2004 Nov;5(11):1149-56. doi: 10.1038/ni1122. Epub 2004 Sep 26.
7
A novel therapy of murine collagen-induced arthritis with soluble T1/ST2.一种用可溶性T1/ST2治疗小鼠胶原诱导性关节炎的新疗法。
J Immunol. 2004 Jul 1;173(1):145-50. doi: 10.4049/jimmunol.173.1.145.
8
IL-10-secreting regulatory T cells do not express Foxp3 but have comparable regulatory function to naturally occurring CD4+CD25+ regulatory T cells.分泌白细胞介素-10的调节性T细胞不表达叉头框蛋白3,但具有与天然存在的CD4+CD25+调节性T细胞相当的调节功能。
J Immunol. 2004 May 15;172(10):5986-93. doi: 10.4049/jimmunol.172.10.5986.
9
Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses.自然产生的CD4+调节性T细胞用于免疫自我耐受和免疫反应的负调控。
Annu Rev Immunol. 2004;22:531-62. doi: 10.1146/annurev.immunol.21.120601.141122.
10
Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3.通过转化生长因子β诱导转录因子Foxp3,使外周CD4+CD25-初始T细胞转化为CD4+CD25+调节性T细胞。
J Exp Med. 2003 Dec 15;198(12):1875-86. doi: 10.1084/jem.20030152.

一氧化氮通过p53、白细胞介素-2和OX40从CD4+CD25 T细胞诱导产生CD4+CD25+Foxp3调节性T细胞。

Nitric oxide induces CD4+CD25+ Foxp3 regulatory T cells from CD4+CD25 T cells via p53, IL-2, and OX40.

作者信息

Niedbala Wanda, Cai Beilei, Liu Haiying, Pitman Nick, Chang Lynda, Liew Foo Y

机构信息

Division of Immunology, Infection, and Inflammation, Glasgow Biomedical Research Centre, 120 University Place, University of Glasgow, Glasgow G12 8TA, United Kingdom.

出版信息

Proc Natl Acad Sci U S A. 2007 Sep 25;104(39):15478-83. doi: 10.1073/pnas.0703725104. Epub 2007 Sep 17.

DOI:10.1073/pnas.0703725104
PMID:17875988
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1978217/
Abstract

The principal aim of the immune system is to establish a balance between defense against pathogens and avoidance of autoimmune disease. This balance is achieved partly through regulatory T cells (Tregs). CD4(+)CD25(+) Tregs are either naturally occurring or induced by antigens and are characterized by the expression of the X-linked forkhead/winged helix transcription factor, Foxp3. Here we report a previously unrecognized subset of CD4(+)CD25(+) Tregs derived from CD4(+)CD25(-) T cells induced by nitric oxide (NO). The induction of Tregs (NO-Tregs) is independent of cGMP but depends on p53, IL-2, and OX40. NO-Tregs produced IL-4 and IL-10, but not IL-2, IFNgamma, or TGFbeta. The cells were GITR(+), CD27(+), T-bet(low), GATA3(high), and Foxp3(-). NO-Tregs suppressed the proliferation of CD4(+)CD25(-) T cells in vitro and attenuated colitis- and collagen-induced arthritis in vivo in an IL-10-dependent manner. NO-Tregs also were induced in vivo in SCID mice adoptively transferred with CD4(+)CD25(-) T cells in the presence of LPS and IFNgamma, and the induction was completely inhibited by N(G)-monomethyl-L-arginine, a pan NO synthase inhibitor. Therefore, our findings uncovered a previously unrecognized function of NO via the NO-p53-IL-2-OX40-survivin signaling pathway for T cell differentiation and development.

摘要

免疫系统的主要目标是在抵御病原体和避免自身免疫性疾病之间建立平衡。这种平衡部分是通过调节性T细胞(Tregs)实现的。CD4(+)CD25(+) Tregs要么是天然存在的,要么是由抗原诱导产生的,其特征是表达X连锁的叉头/翼状螺旋转录因子Foxp3。在此,我们报告了一种先前未被认识的CD4(+)CD25(+) Tregs亚群,它源自一氧化氮(NO)诱导的CD4(+)CD25(-) T细胞。Tregs(NO-Tregs)的诱导不依赖于环鸟苷酸(cGMP),但依赖于p53、白细胞介素-2(IL-2)和OX40。NO-Tregs产生IL-4和IL-10,但不产生IL-2、干扰素γ(IFNγ)或转化生长因子β(TGFβ)。这些细胞为糖皮质激素诱导的肿瘤坏死因子受体(GITR)阳性、CD27阳性、T盒转录因子(T-bet)低表达、GATA结合蛋白3(GATA3)高表达且Foxp3阴性。NO-Tregs在体外抑制CD4(+)CD25(-) T细胞的增殖,并以IL-10依赖的方式在体内减轻结肠炎和胶原诱导的关节炎。在存在脂多糖(LPS)和IFNγ的情况下,将CD4(+)CD25(-) T细胞过继转移到重症联合免疫缺陷(SCID)小鼠体内,也能在体内诱导出NO-Tregs,并且这种诱导被泛NO合酶抑制剂N(G)-单甲基-L-精氨酸完全抑制。因此,我们的研究结果揭示了NO通过NO-p53-IL-2-OX40-生存素信号通路在T细胞分化和发育方面的一种先前未被认识的功能。